Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Isis Pharmaceuticals Inc (NASDAQ:ISIS)

53.05
Delayed Data
As of Jul 29
 -1.35 / -2.48%
Today’s Change
29.17
Today|||52-Week Range
77.80
-14.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues99.1M102.0M147.3M214.2M
 
 
 
 
 
Depreciation And Amortization11.8M10.8M9.8M9.4M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses156.5M159.4M189.2M252.5M
 
 
 
 
 
Research And Development155.5M157.6M181.6M239.5M
 
 
 
 
 
Total Operating Expenses168.3M170.2M199.0M261.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-69.2M-68.1M-51.7M-47.7M
 
 
 
 
 
Extraordinary Charge-1.9M-5.6M---8.3M
 
 
 
 
Pre-Tax Equity Earnings-3.6M-1.4M0.000.00
 
 
 
Interest Expense On Debt16.7M21.2M19.4M22.2M
 
 
 
 
 
Other Expenses4.2M19.8M2.4M21.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-84.8M-74.6M-66.6M-54.4M
 
 
 
 
 
Income Taxes-11.0K-9.1M-5.9M-15.4M
 
 
 
 
 
Net Income-84.8M-65.5M-60.6M-39.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS99.7M100.6M110.5M117.7M
 
 
 
 
 
Shares To Calculate EPS Diluted99.7M100.6M110.5M117.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.85-$0.65-$0.55-$0.33
 
 
 
 
 
EPS Diluted-$0.85-$0.65-$0.55-$0.33